OCEANIC-STROKE shows asundexian cuts ischemic stroke recurrence by 26% in patients taking standard antiplatelet therapy, with no major bleeding increase. New stroke breakthroughs spotlight faster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results